Clinical Studies Group — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$10,320	2
2020	Research	$28,081	8
2019	Research	$49,028	12

Breakdown

Who paid Research payments · program years 2019–2022

Janssen Research & Development, LLC $36,975 13 payments
AbbVie, Inc. $23,650 4 payments
Ucb SA $21,804 4 payments
Bausch Health US, LLC $5,000 1 payment

Studies the money was for Research payments · program years 2019–2022

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study to Evaluate Guselkumab for the Treatment of Subjects with Moderate to Severe Hidradenitis Suppurativa $36,975 13 payments
P10-023 $13,330 2 payments
A Phase 2 Multicenter, Investigator-Blind, Subject-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa $13,248 1 payment
Chronic Plaque Psoriasis (PS) Registry $10,320 2 payments
A Phase 3, Randomized, Double-Blind, Placebocontrolled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa $8,556 3 payments
A Phase 1B Open-Label, Randomized Study Evaluating the Safety and Systemic Pharmacokinetics of Topically Applied Idp-124 Lotion in Pediatric Subjects With Atopic Dermatiti $5,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.